Immunotherapy News and Research

Latest Immunotherapy News and Research

Pembrolizumab enhances breast cancer treatment regardless of age or menopausal status

New data from the KEYNOTE-756 phase 3 clinical trial show that adding the immunotherapy drug, pembrolizumab, to chemotherapy before and after surgery for breast cancer leads to better outcomes for patients regardless of their age or menopausal status.

20 Mar 2024

Immune cell protein identified as potential target for rare liver cancer treatment

Fibrolamellar carcinoma (FLC) is a rare liver cancer with a poor prognosis if not addressed early with surgery. The disease is caused by a single genetic mutation that creates a fusion protein.

20 Mar 2024

Tracking circulating tumor DNA could indicate gastroesophageal cancer treatment response

Monitoring levels of DNA shed by tumors and circulating in the bloodstream could help doctors accurately assess how gastroesophageal cancers are responding to treatment, and potentially predict future prognosis, suggests a new study led by researchers at the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy.

19 Mar 2024

Milk ladder approach offers hope for children with cow's milk allergy

Researchers review milk ladder use for managing cow's milk allergy in children, emphasizing its potential in safely introducing cow's milk to induce tolerance and the need for standardization and further research.

19 Mar 2024

Genetic key to milder COVID: Certain genes slash severity and death risk in older men

Study found that certain genetic variants in the IL1RN gene significantly reduce COVID-19-related inflammation and mortality in patients, with notable improvements observed in older men carrying specific single-nucleotide variants.

19 Mar 2024

Scientists aim to understand why T cells do not sustain energy in tumors

T cells are often called "assassins" or "killers" because they can orchestrate and carry out missions to hunt down bacteria, viruses, and cancer cells throughout the body.

15 Mar 2024

BU study reveals key to combating high-risk neuroblastoma

The MYCN oncoprotein (proteins related to the growth of cancer cells) plays a key role in starting, advancing and making it difficult to treat various human cancers.

15 Mar 2024

Future drug makers can develop their skills using virtual reality at new national Centre of Excellence

Future medicine and vaccine makers will be able to develop their skills using virtual reality at a new national Centre of Excellence, after a successful funding bid involving UCL.

15 Mar 2024

DNA origami vaccine DoriVac paves way for personalized cancer immunotherapy

Therapeutic cancer vaccines are a form of immunotherapy in the making that could not only destroy cancer cells in patients, but keep a cancer from coming back and spreading.

15 Mar 2024

Cedars-Sinai expert explains new treatment options for pediatric patients with sarcomas

Leo Mascarenhas, MD, MS, has an important message for parents whose children have been diagnosed with sarcoma, a type of cancer that develops in the bones or soft tissues.

14 Mar 2024

NCCN updates treatment guidelines for high-incidence cancers

The National Comprehensive Cancer Network is announcing several new updates to the cancer treatment practices listed in the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines).

14 Mar 2024

Researchers find link between gut bacteria and the success of milk-allergy oral immunotherapy

Researchers led by Hiroshi Ohno at the RIKEN Center for Integrative Medical Sciences in Japan have discovered a link between gut bacteria and the success of milk-allergy oral immunotherapy.

14 Mar 2024

Novel CAR-T therapy shows promising results in glioblastoma patients

A collaborative project to bring the promise of cell therapy to patients with a deadly form of brain cancer has shown dramatic results among the first patients to receive the novel treatment.

13 Mar 2024

Blood test shows 83% accuracy in detecting colorectal cancer

A blood test intended for screening for colorectal cancer in people who are of average risk and not experiencing symptoms correctly detected colorectal cancer in 83% of people confirmed to have the disease, according to a study published March 14 in the New England Journal of Medicine.

13 Mar 2024

Novel dual-target CAR T cell therapy shows promise in treating recurrent glioblastoma

Targeting two brain tumor-associated proteins-;rather than one-;with CAR T cell therapy shows promise as a strategy for reducing solid tumor growth in patients with recurrent glioblastoma (GBM), an aggressive form of brain cancer, according to early results from the first six patients treated in an ongoing Phase I clinical trial led by researchers from the Perelman School of Medicine at the University of Pennsylvania and Penn Medicine's Abramson Cancer Center.

13 Mar 2024

Exploring the power of diet: A new frontier in disease management and cancer treatment

The therapeutic potential of and molecular mechanisms through which dietary interventions impact a wide range of human diseases.

13 Mar 2024

Bormioli Pharma Expands Capacity and Infrastructure for North American Market

...

From Bormioli Pharma S.p.A. 13 Mar 2024

LAG-3 protein structure may be the key to unlocking new cancer treatments

A molecular “snapshot” of a protein can be critical to understanding its function. Scientists at Stanford and NYU have published and investigated a new structure of the protein LAG-3 which could enable the development of new cancer treatments.

11 Mar 2024

AI method can predict brain metastasis in lung cancer patients

Physicians treating patients with early-stage lung cancer face a conundrum: choosing potentially helpful yet toxic therapies such as chemotherapy, radiation or immunotherapy to knock out the cancer and lessen the risk of it spreading to the brain, or waiting to see if lung surgery alone proves sufficient.

11 Mar 2024

An Arm and a Leg: The Medicare episode

Medicare may sound like an escape from the expensive world of U.S. health insurance, but it's more complicated, and expensive, than many realize.

11 Mar 2024

Immunotherapy News and Research

Latest Immunotherapy News and Research

Pembrolizumab enhances breast cancer treatment regardless of age or menopausal status

Immune cell protein identified as potential target for rare liver cancer treatment

Tracking circulating tumor DNA could indicate gastroesophageal cancer treatment response

Milk ladder approach offers hope for children with cow's milk allergy

Genetic key to milder COVID: Certain genes slash severity and death risk in older men

Scientists aim to understand why T cells do not sustain energy in tumors

BU study reveals key to combating high-risk neuroblastoma

Future drug makers can develop their skills using virtual reality at new national Centre of Excellence

DNA origami vaccine DoriVac paves way for personalized cancer immunotherapy

Cedars-Sinai expert explains new treatment options for pediatric patients with sarcomas

NCCN updates treatment guidelines for high-incidence cancers

Researchers find link between gut bacteria and the success of milk-allergy oral immunotherapy

Novel CAR-T therapy shows promising results in glioblastoma patients

Blood test shows 83% accuracy in detecting colorectal cancer

Novel dual-target CAR T cell therapy shows promise in treating recurrent glioblastoma

Exploring the power of diet: A new frontier in disease management and cancer treatment

Bormioli Pharma Expands Capacity and Infrastructure for North American Market

LAG-3 protein structure may be the key to unlocking new cancer treatments

AI method can predict brain metastasis in lung cancer patients

An Arm and a Leg: The Medicare episode

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Immunotherapy News and Research

Latest Immunotherapy News and Research

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Newsletters you may be interested in